ID   PER-785S
AC   CVCL_IZ04
DR   Wikidata; Q54947222
RX   PubMed=27443263;
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line is no longer in use (personal communication of Kotecha, Rishi S.).
ST   Source(s): PubMed=27443263
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9
ST   D21S11: 30,30.2
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C122617; Infant acute lymphoblastic leukemia with MLL rearrangement
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IZ03 ! PER-785
SX   Female
AG   2M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
RX   PubMed=27443263; DOI=10.1038/leu.2016.165; PMCID=PMC5220136;
RA   Cruickshank M.N., Ford J., Cheung L.C., Heng J., Singh S., Wells J.,
RA   Failes T.W., Arndt G.M., Smithers N., Prinjha R.K., Anderson D.,
RA   Carter K.W., Gout A.M., Lassmann T., O'Reilly J., Cole C.H.,
RA   Kotecha R.S., Kees U.R.;
RT   "Systematic chemical and molecular profiling of MLL-rearranged infant
RT   acute lymphoblastic leukemia reveals efficacy of romidepsin.";
RL   Leukemia 31:40-50(2017).
//